다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
생물정신의학 = Korean journal of biological psychiatry, v.29 no.1, 2022년, pp.22 - 31
김수영 (가톨릭대학교 의과대학 서울성모병원 정신건강의학교실) , 김태석 (가톨릭대학교 의과대학 서울성모병원 정신건강의학교실) , 김대진 (가톨릭대학교 의과대학 서울성모병원 정신건강의학교실) , 채정호 (가톨릭대학교 의과대학 서울성모병원 정신건강의학교실) , 이창욱 (가톨릭대학교 의과대학 서울성모병원 정신건강의학교실) , 주수현 (가톨릭대학교 의과대학 서울성모병원 정신건강의학교실)
AI-Helper
Objectives Recently, weight loss has emerged as a national concern in South Korea, and this has resulted in an increase in the frequency of use of central nervous system (CNS)-stimulating appetite suppressants. This study aimed to collect cases of psychotic disorders and bipolar disorders triggered ...
World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and Is Treatment. Sydney: Health Communications Australia;2000.
Korea Disease Control and Prevention Agency. Korea Health Statistics 2019: Korea National Health and Nutrition Examination Survey (KNHANES VIII-1). Cheongju: Korea Disease Control and Prevention Agency;2020.
Kosis.kr [homepage on the Internet]. Korea: Ministry of Food and Drug Safety [updated 2021 July 23; cited 2022 Feb 18]. Available from: https://kosis.kr/statHtml/statHtml.do?orgId145&tblIdDT_145013_044&conn_pathI2.
Seo MH, Kim YH, Han K, Jung JH, Park YG, Lee SS, et al. Prevalence of obesity and incidence of obesity-related comorbidities in Koreans based on National Health Insurance Service health checkup data 2006-2015. J Obes Metab Syndr 2018;27:46-52.
Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean Society for the study of obesity guideline for the management of obesity in Korea. J Obes Metab Syndr 2019;28:40-45.
Bray GA, Heisel WE, Afshin A, Jensen MD, Dietz WH, Long M, et al. The science of obesity management: an endocrine society scientific statement. Endocr Rev 2018;39:79-132.
Jo SJ, Lee HK, Park BJ, Kang HC, Lee SY, Jo JB. A rapid systematic review on adverse effects of psychostimulant appetite suppressants: focusing on dependence and psychosis. J Korean Academy of Addiction Psychiatry 2021;25:45-57.
Rothman RB, Baumann MH. Appetite suppressants, cardiac valve disease and combination pharmacotherapy. Am J Ther 2009;16:354-364.
Kim KK. Mechanisms of action and clinical applications of antiobesity drugs currently available in Korea. J Korean Med Assoc 2019;62:588-597.
Bramness JG, Gundersen OH, Guterstam J, Rognli EB, Konstenius M, Loberg EM, et al. Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable? BMC Psychiatry 2012;12:221.
Rubin RT. Acute psychotic reaction following ingestion of phentermine. Am J Psychiatry 1964;120:1124-1125.
Homola J, Hieber R. Combination of venlafaxine and phentermine/topiramate induced psychosis: a case report. Ment Health Clin 2018;8:95-99.
Alexander J, Cheng YH, Choudhary J, Dinesh A. Phentermine (Duromine) precipitated psychosis. Aust N Z J Psychiatry 2011;45:684-685.
Lee SH, Liu CY, Yang YY. Schizophreniform-like psychotic disorder induced by phentermine: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1998;61:44-47.
Cleare AJ. Phentermine, psychosis, and family history. J Clin Psychopharmacol 1996;16:470-471.
Devan GS. Phentermine and psychosis. Br J Psychiatry 1990;156:442-443.
Hoffman BF. Diet pill psychosis: follow-up after 6 years. Can Med Assoc J 1983;129:1077-1078.
Hoffman BF. Diet pill psychosis. Can Med Assoc J 1977;116:351-355.
Raison CL, Klein HM. Psychotic mania associated with fenfluramine and phentermine use. Am J Psychiatry 1997;154:711.
Bagri S, Reddy G. Delirium with manic symptoms induced by diet pills. J Clin Psychiatry 1998;59:83.
Zimmer JE, Gregory RJ. Bipolar depression associated with fenfluramine and phentermine. J Clin Psychiatry 1998;59:383-384.
Kim SH, Ahn DH, Yoo TH. A case of organic hallucinous following phendimetrazine(Fringar@) abuse. J Korean Neuropsychiatr Assoc 1992;31:1119-1122.
Lee JM, Lee KU, Jhoo JH, Park JI. Two cases of psychotic disorder following phendimetrazine use. Korean J Psychopharmacol 2010;21:95-98.
Yun JA, Park WR, Yu JC, Choi KS. A case of phendimetrazine induced-psychotic disorder and dependence. J Korean Neuropsychiatr Assoc 2013;52:402-405.
Kwak SY, Youn TY, Lee NY, Chung IW, Kim SH. Psychotic disorder induced by appetite suppressants, phentermine or phendimetrazine: a case series study. Korean J Biol Psychiatry 2017;24:134-141.
Jo HS, Wang SM, Kim JJ. Recurrent psychosis after phentermine administration in a young female: a case report. Clin Psychopharmacol Neurosci 2019;17:130-133.
Starzer MSK, Nordentoft M, Hjorthoj C. Rates and predictors of conversion to schizophrenia or bipolar disorder following substance-induced psychosis. Am J Psychiatry 2018;175:343-350.
Sadock BJ, Sadock VA, Ruiz P. Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry. 11th ed. Philadelphia: Lippincott Williams & Wilkins;2015.
Baumann MH, Ayestas MA, Dersch CM, Brockington A, Rice KC, Rothman RB. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications. Synapse 2000;36:102-113.
Solis E Jr, Suyama JA, Lazenka MF, DeFelice LJ, Negus SS, Blough BE, et al. Dissociable effects of the prodrug phendimetrazine and its metabolite phenmetrazine at dopamine transporters. Sci Rep 2016;6:31385.
An H, Sohn H, Chung S. Phentermine, sibutramine and affective disorders. Clin Psychopharmacol Neurosci 2013;11:7-12.
Niemi-Pynttari JA, Sund R, Putkonen H, Vorma H, Wahlbeck K, Pirkola SP. Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. J Clin Psychiatry 2013;74:e94-e99.
Chen WL, Hsieh CH, Chang HT, Hung CC, Chan CH. The epidemiology and progression time from transient to permanent psychiatric disorders of substance-induced psychosis in Taiwan. Addict Behav 2015;47:1-4.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.